Analysis of the satisfaction survey results of users of the Mobile Drug Consumption Room Program in Lisbon

This abstract delves into the outcomes of a satisfaction survey conducted among users of the Mobile Drug Consumption Room Program (MDCRP), managed by Médicos do Mundo and financially supported by the Institute for Addictive Behaviors and Dependencies, in collaboration with the Lisbon City Council. 
Supervised drug consumption facilities play a vital role in establishing and maintaining contact with high risk people who use drugs who may not be ready to cease drug consumption. This approach yields health benefits, ensuring enhanced safety and hygiene during drug injection, particularly for regular users, leading to a reduction in overdose situations. These facilities also provide crucial access to health services and social responses, contributing to a decline in public drug consumption. 
Recognized as frontline services with low thresholds, supervised drug consumption rooms are often at the forefront of identifying emerging substance use patterns. As a result, they play a important role in the early detection of trends among high-risk populations. Given this context, it becomes crucial to understand the opinions of individuals accessing these services and provide them with a platform to voice their experiences. 

This study aims to gain insights into users' perceptions of the Mobile Monitored Consumption Program. Specific objectives included identifying reasons for service utilization, analyzing positive aspects, and collecting suggestions for service improvement. The survey comprising 23 open and closed questions, was runed by an external member not affiliated with the project. 
The sample was obtained through convenience sampling,  Anonymity and data confidentiality were ensured throughout the survey. The questionnaire addressed sociodemographic characteristics, consumption patterns, and awareness of supervised consumption programs in Lisbon. Data from this survey were collected using the Google Forms® platform and subjected to statistical analysis. 

In January, 49 out of 96 MDCRP users visited the Mobile Unit (MU) during the questionnaire period, yielding a sample of 21 respondents. Of these, 95.2% use drugs, with 76.2% having used intravenous (IV) drugs, and 38.1% having consumed IV drugs in the UM.  All respondents (100%) deem MDCRP existence very important, citing reasons such as Psychosocial Support, Food Support, Hygiene Support, and Replacement of Smoking Material  Consumption. Satisfaction levels are notably high, with 95% expressing contentment, and 4.8% reporting satisfaction. In summary, users exhibit a substantial level of satisfaction with MDCRP services. Prioritizing user well-being, assessing MU  satisfaction is crucial. This valuable feedback can be used, to amplifying the voices of those benefiting. However, the significance of IV consumption assistance is less evident, warranting further  investigation. Future efforts should be concentraded at user suggestions for service enhancement, ensuring continual alignment with user needs.